Scilex Holding (SCLX) Asset Utilization Ratio (2022 - 2026)
Scilex Holding (SCLX) posted quarterly Asset Utilization Ratio of 0.1 for Q1 2026, down 82.55% year-over-year from 0.59 in Q1 2025, and up 8.87% on a QoQ basis from 0.09 in Q4 2025.
Scilex Holding (SCLX) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Asset Utilization Ratio for 5 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 82.55% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (down 82.55% YoY), while the FY2025 annual figure was 0.13, down 77.29% from the prior year.
- Asset Utilization Ratio came in at 0.1 for Q1 2026 at Scilex Holding, up from 0.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.59 in Q1 2025, with the low at 0.09 in Q4 2025.
- Average Asset Utilization Ratio over 5 years is 0.43, with a median of 0.49 recorded in 2023.
- Across the five-year window, Asset Utilization Ratio climbed 27.05% in 2023 and tumbled 83.85% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.4 in 2022, then gained by 27.05% to 0.51 in 2023, then rose by 13.84% to 0.59 in 2024, then slumped by 83.85% to 0.09 in 2025, then rose by 8.87% to 0.1 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.1, 0.09, and 0.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.63 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.48 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.46 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 0.50 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.12 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.54 |
| Mar 31, 2025 | 0.59 |
| Dec 31, 2024 | 0.59 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | 0.52 |
| Mar 31, 2024 | 0.49 |
| Dec 31, 2023 | 0.51 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.40 |